First, Apple said CEO Steve Jobs’ gaunt appearance at the annual January keynote speech was caused by nothing more than a “nutritional problem.” Then he announced he’d be taking some time off from running the company. Now it has been revealed that he’s had a liver transplant. Apple did not inform shareholders or the public of the procedure. In this hour, we discuss corporate transparency and when shareholders should be informed about the health of key company officials.

Sam Diaz, Senior Editor at ZD Net
Dan Gillmor, director of the Knight Center for Digital Media Entrepreneurship.
Kellie McElhaney, co-faculty director and adjunct assistant professor at UC Berkeley's Center for Responsible Business

Sponsored by

Become a KQED sponsor